Histologic grading of urothelial carcinoma: a reappraisal

Mostofi, 1973 Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001 Mostofi, 1999 Eble, 2004 Montironi, 2003, Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies, J Clin Pathol, 56, 91, 10.1136/jcp.56.2.91 MacLennan, 2007, Histologic grading of noninvasive papillary urothelial neoplasms, Eur Urol, 51, 889, 10.1016/j.eururo.2006.10.037 Jones, 2006, Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts, J Urol, 175, 1995, 10.1016/S0022-5347(06)00267-9 Bostwick, 2002, Urothelial papillary (exophytic) neoplasms, Virchows Arch, 441, 109, 10.1007/s00428-002-0624-y Lopez-Beltran, 2004, Non-invasive urothelial neoplasms: according to the most recent WHO classification, Eur Urol, 46, 170, 10.1016/j.eururo.2004.03.017 Montironi, 2009, 2004 World Health Organization classification of the noninvasive urothelial neoplasms: inherent problems and clinical reflections, Eur Urol, 453, 10.1016/j.eursup.2008.12.004 Bostwick, 1999, Diagnosis and grading of bladder cancer and associated lesions, Urol Clin North Am, 26, 493, 10.1016/S0094-0143(05)70197-X Montironi, 2008, Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder, Histopathology, 53, 621, 10.1111/j.1365-2559.2008.03025.x Montironi, 2008, Morphological diagnosis of urothelial neoplasms, J Clin Pathol, 61, 3, 10.1136/jcp.2007.049312 Pich, 2002, Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder, Cancer, 95, 784, 10.1002/cncr.10733 Oosterhuis, 2002, Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems, J Clin Pathol, 55, 900, 10.1136/jcp.55.12.900 Pich, 2001, Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder, Am J Surg Pathol, 25, 1528, 10.1097/00000478-200112000-00009 Holmang, 1999, Recurrence and progression in low grade papillary urothelial tumors, J Urol, 162, 702, 10.1097/00005392-199909010-00019 Fujii, 2003, Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential, BJU Int, 92, 559, 10.1046/j.1464-410X.2003.04415.x Cheng, 2004, Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder, Cancer, 101, 183, 10.1002/cncr.20343 Coblentz, 2001, Impact of second opinion pathology in the definitive management of patients with bladder carcinoma, Cancer, 91, 1284, 10.1002/1097-0142(20010401)91:7<1284::AID-CNCR1130>3.0.CO;2-E Mikuz, 2001, The reliability and reproducibility of the different classifications of bladder cancer, 114 Otto, 2010, The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer, BJU Int, 107, 404, 10.1111/j.1464-410X.2010.09515.x Cheng, 2000, World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors: reply, Cancer, 88, 1513, 10.1002/(SICI)1097-0142(20000401)88:7<1513::AID-CNCR2>3.0.CO;2-G Sylvester, 2006, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials, Eur Urol, 49, 466, 10.1016/j.eururo.2005.12.031 van Rhijn, 2009, Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy, Eur Urol, 56, 430, 10.1016/j.eururo.2009.06.028 Yorukoglu, 2003, Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder, Virchows Arch, 443, 734, 10.1007/s00428-003-0905-0 Schned, 2007, Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems, J Urol, 178, 1196, 10.1016/j.juro.2007.05.126 Murphy, 2002, Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care, J Urol, 168, 968, 10.1016/S0022-5347(05)64553-3 Bol, 2003, Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder, J Urol, 169, 1291, 10.1097/01.ju.0000055471.78783.ae Engers, 2007, Reproducibility and reliability of tumor grading in urological neoplasms, World J Urol, 25, 595, 10.1007/s00345-007-0209-0 May, 2010, Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications, Eur Urol, 57, 850, 10.1016/j.eururo.2009.03.052 van Rhijn, 2010, The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading, Eur Urol, 57, 1052, 10.1016/j.eururo.2009.09.022 Gonul, 2007, Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases, Urol Int, 78, 338, 10.1159/000100839 Cheng, 2008, Neoplasms of the urinary bladder, 259 Cheng, 2009, Staging and reporting of urothelial carcinoma of the urinary bladder, Mod Pathol, 22, S70, 10.1038/modpathol.2009.1 Hofmann, 2006, Clinical implications of the 2004 WHO histological classification on non-invasive tumours of the urinary bladder, EAU-EBU Update Series, 4, 83, 10.1016/j.eeus.2006.03.002 Cheng, 1999, Urothelial papilloma of the bladder. Clinical and biologic implications, Cancer, 86, 2098, 10.1002/(SICI)1097-0142(19991115)86:10<2098::AID-CNCR30>3.0.CO;2-9 Malmstrom, 1987, Recurrence, progression, and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up, Scand J Urol Nephrol, 21, 185, 10.3109/00365598709180320 Prout, 1992, Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group, J Urol, 148, 1413, 10.1016/S0022-5347(17)36924-0 Holmang, 1995, The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years, J Urol, 153, 1823, 10.1016/S0022-5347(01)67321-X England, 1981, The correlation of T1 bladder tumour history with prognosis and follow-up requirements, Br J Urol, 53, 593, 10.1111/j.1464-410X.1981.tb03268.x Leblanc, 1999, Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder, J Urol, 162, 1946, 10.1016/S0022-5347(05)68075-5 Pocock, 1982, Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report, Br J Urol, 54, 711, 10.1111/j.1464-410X.1982.tb13631.x Gilbert, 1978, The natural history of papillary transitional cell carcinoma of the bladder and its treatment in any unselected population on the basis of histologic grading, J Urol, 119, 488, 10.1016/S0022-5347(17)57526-6 Heney, 1983, Superficial bladder cancer: progression and recurrence, J Urol, 130, 1083, 10.1016/S0022-5347(17)51695-X Fitzpatrick, 1986, Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection, J Urol, 135, 920, 10.1016/S0022-5347(17)45923-4 Prout, 1986, The treated histories of patients with Ta grade 1 transitional-cell carcinoma of the bladder, Arch Surg, 121, 1463, 10.1001/archsurg.1986.01400120113018 Hemstreet, 1991, Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue, J Urol, 146, 1525, 10.1016/S0022-5347(17)38157-0 Mufti, 1990, ‘Solitary’ Ta-T1 G1 bladder tumour—history and long-term prognosis, Eur Urol, 18, 101, 10.1159/000463883 Jordan, 1987, Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading, Cancer, 60, 2766, 10.1002/1097-0142(19871201)60:11<2766::AID-CNCR2820601129>3.0.CO;2-0 Fitzpatrick, 1993, Superficial bladder carcinoma, World J Urol, 11, 142, 10.1007/BF00211408 Greene, 1973, Benign papilloma or papillary carcinoma of the bladder, J Urol, 110, 205, 10.1016/S0022-5347(17)60161-7 Bostwick, 1992, Natural history of early bladder cancer, J Cell Biochem, 161, 31, 10.1002/jcb.240501307 Pauwels, 1988, Grading in superficial bladder cancer: morphological criteria, Br J Urol, 61, 129, 10.1111/j.1464-410X.1988.tb05060.x Schapers, 1994, A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters, Br J Urol, 73, 625, 10.1111/j.1464-410X.1994.tb07546.x Carbin, 1991, Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I. Histological description, J Urol, 145, 968, 10.1016/S0022-5347(17)38502-6 Lipponen, 1991, Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction, J Urol, 146, 1535, 10.1016/S0022-5347(17)38159-4 Bostwick, 1999 Alsheikh, 2001, Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World Health Organization/International Society of Urologic Pathology, Mod Pathol, 14, 267, 10.1038/modpathol.3880300 Alvarez, 2001, Clinico-pathologic differences between bladder neoplasm with low malignant potential and low-grade carcinoma, Actas Urol Esp, 25, 645 Montironi, 2005, The 2004 WHO classification of bladder tumors: a summary and commentary, Int J Surg Pathol, 13, 143, 10.1177/106689690501300203 Cheng, 1999, Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications, Cancer, 86, 2102, 10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.0.CO;2-U Pan, 2010, Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non–muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases, Am J Clin Pathol, 133, 788, 10.1309/AJCP12MRVVHTCKEJ Samaratunga, 2002, Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression, Urology, 60, 315, 10.1016/S0090-4295(02)01705-3 Holmang, 2001, Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy, J Urol, 165, 1124, 10.1016/S0022-5347(05)66443-9 Lee, 2011, Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center, Hum Pathol, 42, 1799, 10.1016/j.humpath.2011.03.006 Oyasu, 2000, World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors, Cancer, 88, 1509, 10.1002/(SICI)1097-0142(20000401)88:7<1509::AID-CNCR1>3.0.CO;2-G Cheng, 2000, Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens, Am J Clin Pathol, 113, 275, 10.1309/94B6-8VFB-MN9J-1NF5 Herr, 2007, Management of low grade papillary bladder tumors, J Urol, 178, 1201, 10.1016/j.juro.2007.05.148 Miyamoto, 2010, Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post–World Health Organization/International Society of Urological Pathology classification cohort from a single academic center, Arch Pathol Lab Med, 134, 1160, 10.5858/2009-0403-OA.1 Pellucchi, 2011, Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors, J Urol, 186, 2194, 10.1016/j.juro.2011.07.070 Habuchi, 1993, Accumulated allelic losses in the development of invasive urothelial cancer, Int J Cancer, 53, 5093, 10.1002/ijc.2910530409 Chaux, 2012, High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post–World Health Organization/International Society of Urological Pathology classification cohort from a single academic center, Hum Pathol, 43, 115, 10.1016/j.humpath.2011.04.013 Whisnant, 2003, Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification, Diagn Cytopathol, 28, 186, 10.1002/dc.10263 Bircan, 2004, Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma, Urol Int, 73, 201, 10.1159/000080828 Yin, 2004, Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up, Am J Clin Pathol, 121, 679, 10.1309/0KATYHQBJD5XHQ8J Curry, 2002, The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results, Cancer, 96, 140, 10.1002/cncr.10621 Ramos, 2003, Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder, Cancer, 97, 1876, 10.1002/cncr.11265 Burger, 2008, Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?, BJU Int, 102, 194, 10.1111/j.1464-410X.2008.07538.x Campbell, 2004, Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome, BJU Int, 93, 1228, 10.1111/j.1464-410X.2004.04848.x Desai, 2000, Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia, Mod Pathol, 13, 1315, 10.1038/modpathol.3880241 Cheng, 2000, Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma, Cancer, 88, 1663, 10.1002/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8 Eble, 1989, Benign and low grade papillary lesions of the urinary bladder: a review of the papilloma–papillary carcinoma controversy and a report of five typical papillomas, Sem Diagn Pathol, 6, 351 Burger, 2008, Prediction of progression of non–muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study, Eur Urol, 54, 835, 10.1016/j.eururo.2007.12.026 Cheng, 2011, Bladder cancer: translating molecular genetic insights into clinical practice, Hum Pathol, 42, 455, 10.1016/j.humpath.2010.07.007